212 related articles for article (PubMed ID: 24864240)
1. Microarray analysis of serum mRNA in patients with head and neck squamous cell carcinoma at whole-genome scale.
Čapková M; Šáchová J; Strnad H; Kolář M; Hroudová M; Chovanec M; Čada Z; Šteffl M; Valach J; Kastner J; Vlček Č; Smetana K; Plzák J
Biomed Res Int; 2014; 2014():408683. PubMed ID: 24864240
[TBL] [Abstract][Full Text] [Related]
2. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
El Baroudi M; Machiels JP; Schmitz S
Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Koczan D; Knecht R; Kramp B; Dommerich S
Cancer Genomics Proteomics; 2013; 10(5):197-207. PubMed ID: 24136972
[TBL] [Abstract][Full Text] [Related]
6. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma.
Victoria Martinez B; Dhahbi JM; Nunez Lopez YO; Lamperska K; Golusinski P; Luczewski L; Kolenda T; Atamna H; Spindler SR; Golusinski W; Masternak MM
Oncotarget; 2015 Aug; 6(22):19246-63. PubMed ID: 26057471
[TBL] [Abstract][Full Text] [Related]
7. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma.
Braakhuis BJ; Graveland AP; Dijk F; Ylstra B; van Wieringen WN; Leemans CR; Brakenhoff RH
Oral Dis; 2013 Jul; 19(5):452-5. PubMed ID: 23034102
[TBL] [Abstract][Full Text] [Related]
8. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma.
Lu CT; Hsu CM; Lin PM; Lai CC; Lin HC; Yang CH; Hsiao HH; Liu YC; Lin HY; Lin SF; Yang MY
Anticancer Res; 2014 Dec; 34(12):7137-43. PubMed ID: 25503141
[TBL] [Abstract][Full Text] [Related]
9. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
10. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma.
Mohtasham N; Ayatollahi H; Saghravanian N; Zare R; Shakeri MT; Sahebkar A; Mohajertehran F
Anticancer Agents Med Chem; 2019; 19(17):2072-2078. PubMed ID: 31660843
[TBL] [Abstract][Full Text] [Related]
13. Monocyte CD40 expression in head and neck squamous cell carcinoma (HNSCC).
Sathawane D; Kharat RS; Halder S; Roy S; Swami R; Patel R; Saha B
Hum Immunol; 2013 Jan; 74(1):1-5. PubMed ID: 23000501
[TBL] [Abstract][Full Text] [Related]
14. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
15. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
16. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
Rahman MA; Amin AR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG; Shin DM
Clin Cancer Res; 2013 Jul; 19(13):3416-28. PubMed ID: 23719266
[TBL] [Abstract][Full Text] [Related]
17. Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma.
Warta R; Theile D; Mogler C; Herpel E; Grabe N; Lahrmann B; Plinkert PK; Herold-Mende C; Weiss J; Dyckhoff G
PLoS One; 2014; 9(9):e108908. PubMed ID: 25275603
[TBL] [Abstract][Full Text] [Related]
18. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
19. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
[TBL] [Abstract][Full Text] [Related]
20. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
